DS

Koninklijke DSM NVAMS Koninklijke DSM Stock Report

Last reporting period 31 Dec, 2022

Updated —

Last price

Market cap $B

0.854

Micro

Exchange

XAMS - Euronext Amsterdam

DSM.AS Stock Analysis

DS

Uncovered

Koninklijke DSM NV is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

55/100

Moderate score

Market cap $B

0.854

Dividend yield

Shares outstanding

173.08 B

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 20,682 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.

View Section: Eyestock Rating